Patents by Inventor Howard Clark

Howard Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8865643
    Abstract: We describe an rspd(n/CRD) polypeptide, fragment, homologue, variant or derivative thereof for use in a method of treatment or prophylaxis of a disease. A method of treating an individual suffering from a disease or preventing the occurrence of a disease in an individual is also described, in which the method comprises administering to the individual a therapeutically or prophylactically effective amount of an rspd (n/CRD) polypeptide, fragment, homologue, variant or derivative thereof. Preferably, the rspd (n/CRD) polypeptide and nucleic acid comprise SEQ ID NO: 1 and SEQ ID NO: 2, respectively.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: October 21, 2014
    Assignee: Medical Research Council
    Inventors: Howard Clark, Palaniyar Nadesalingam, Kenneth B. Reld, Peter Strong
  • Publication number: 20120010126
    Abstract: We describe an rspd(n/CRD) polypeptide, fragment, homologue, variant or derivative thereof for use in a method of treatment or prophylaxis of a disease. A method of treating an individual suffering from a disease or preventing the occurrence of a disease in an individual is also described, in which the method comprises administering to the individual a therapeutically or prophylactically effective amount of an rspd (n/CRD) polypeptide, fragment, homologue, variant or derivative thereof. Preferably, the rspd (n/CRD) polypeptide and nucleic acid comprise SEQ ID NO: 1 and SEQ ID NO: 2, respectively.
    Type: Application
    Filed: February 3, 2011
    Publication date: January 12, 2012
    Applicant: Medical Research Council
    Inventors: Howard Clark, Palaniyar Nadesalingam, Kenneth Bannerman Milne Reid, Peter Strong
  • Publication number: 20070120422
    Abstract: A method and apparatus for providing power in an electrical system is disclosed. The electrical system comprises: a poly-phase electrical source; a plurality of transformers coupled to each other, where each phase of the poly-phase source is coupled to a transformer within the plurality. The electrical system further comprises a plurality of loads, where each load is coupled to a tap point on one of the transformers and where the transformers are capable of being severed at their common connections and coupled to a neutral line.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 31, 2007
    Inventor: Howard Clark
  • Publication number: 20070097716
    Abstract: A power control system includes a power reduction module operable to reduce power to a connected load, a switching module operable to selectively transfer power directly to the load or to the power reduction module, a harmonic reduction module connected to an output of the power reduction module for reducing signal harmonics from power transferred to the load, a controller linked to the switching module to provide control signals, a resistor coupled between the switching module and the power reduction module, and a resistor voltage monitor coupled between the switching module and the resistor, wherein the resistor voltage monitor measures a voltage across the resistor and sends voltage measurement data to the controller. A method for a power control system to reduce power consumption of a load is also disclosed.
    Type: Application
    Filed: November 3, 2005
    Publication date: May 3, 2007
    Inventors: Howard Clark, Howard Clark
  • Publication number: 20040259201
    Abstract: We describe an rSPD(n/CRD) polypeptide, fragment, homologue, variant or derivative thereof for use in a method of treatment or prophylaxis of a disease. A method of treating an individual suffering from a disease or preventing the occurrence of a disease in an individual is also described, in which the method comprises administering to the individual a therapeutically or prophylactically effective amount of an rSPD (n/CRD) polypeptide, fragment, homologue, variant or derivative thereof. Preferably, the rSPD (n/CRD) polypeptide and nucleic acid comprise SEQ ID NO: 1 and SEQ ID NO: 2, respectively.
    Type: Application
    Filed: April 23, 2004
    Publication date: December 23, 2004
    Applicant: Medical Research Council
    Inventors: Howard Clark, Palaniyar Nadesalingam, Kenneth Bannerman Milne Reid, Peter Strong